Operating Expenses
Incyte·Income Statement·8 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total operating expenses | $1.5B | $991.8M | $877.2M | $847.7M | $685.2M | $922.5M | $1.2B | $971.6M |
| Research and development | $1.1B | $573.2M | $466M | $437.3M | $494.9M | $506.6M | $611.4M | $515.9M |
| Selling, general and administrative | $306M | $309.2M | $326.7M | $325.7M | $331M | $329.1M | $390.4M | $328.1M |
| Impairment charges | $0 | $0 | $0 | $0 | — | — | — | $23.2M |
| Impairment of Goodwill and Purchased Intangible Assets | $0 | $0 | $0 | $0 | $19.1M | $19.1M | $19.1M | $23.2M |
| Goodwill and indefinite-lived intangible asset impairment | $0 | $0 | $0 | $0 | $19.1M | $19.1M | $19.1M | $23.2M |
| Change in contingent consideration liability | $893K | $23.4M | — | $11.6M | $22.8M | -$12.2M | -$28.3M | -$168K |
| Contingent consideration fair value adjustment | $893K | $23.4M | — | $11.6M | $22.8M | -$12.2M | -$28.3M | -$168K |